{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:29:12Z","timestamp":1783031352474,"version":"3.54.6"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12149-017-1180-5","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T14:48:32Z","timestamp":1494514112000},"page":"425-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pathogenesis and FDG-PET\/CT findings of Epstein\u2013Barr virus-related lymphoid neoplasms"],"prefix":"10.1007","volume":"31","author":[{"given":"Akira","family":"Toriihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nakadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"1180_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11604-008-0291-2","volume":"27","author":"E Maeda","year":"2009","unstructured":"Maeda E, Akahane M, Kiryu S, Kato N, Yoshikawa T, Hayashi N, et al. Spectrum of Epstein\u2013Barr virus-related diseases: a pictorial review. Jpn J Radiol. 2009;27:4\u201319.","journal-title":"Jpn J Radiol"},{"key":"1180_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.beha.2012.01.005","volume":"25","author":"M Roschewski","year":"2012","unstructured":"Roschewski M, Wilson WH. EBV-associated lymphomas in adults. Best Pract Res Clin Haematol. 2012;25:75\u201389.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1180_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46:218\u201323.","journal-title":"Br J Surg"},{"key":"1180_CR4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Anchong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet. 1964;1:702\u20133.","journal-title":"Lancet"},{"key":"1180_CR5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H Zur Hausen","year":"1970","unstructured":"Zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970;228:1056\u20138.","journal-title":"Nature"},{"key":"1180_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein\u2013Barr virus infection. N Engl J Med. 2000;343:481\u201392.","journal-title":"N Engl J Med"},{"key":"1180_CR7","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"LS Young","year":"2003","unstructured":"Young LS, Murray PG. Epstein\u2013Barr virus and oncogenesis: from latent genes to tomours. Oncogene. 2003;22:5108\u201321.","journal-title":"Oncogene"},{"key":"1180_CR8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"key":"1180_CR9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","volume":"149","author":"K Klapproth","year":"2010","unstructured":"Klapproth K, Wirth T. Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol. 2010;149:484\u201397.","journal-title":"Br J Haematol"},{"key":"1180_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25\u201330.","journal-title":"J Nucl Med"},{"key":"1180_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/RLU.0b013e3181a34552","volume":"34","author":"W Zeng","year":"2009","unstructured":"Zeng W, Lechowicz MJ, Winton E, Cho SM, Galt JR, Halkar R. Spectrum of FDG PET\/CT findings in Burkitt lymphoma. Clin Nucl Med. 2009;34:355\u20138.","journal-title":"Clin Nucl Med"},{"key":"1180_CR12","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2010","unstructured":"Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, et al. 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol. 2010;75:e68\u201373.","journal-title":"Eur J Radiol"},{"key":"1180_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/ejh.12284","volume":"94","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga VA, Rodriguez MS, Borrego-Dorado I, Vicente CF, Cantero EQ, et al. Role of 18F-FDG-PET\/CT in the management of Burkitt lymphoma. Eur J Haematol. 2015;94:23\u201330.","journal-title":"Eur J Haematol"},{"key":"1180_CR14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/asheducation.V2012.1.328.3798326","volume":"2012","author":"R Kuppers","year":"2012","unstructured":"Kuppers R. New insights in the biology of Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program. 2012;2012:328\u201334.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1180_CR15","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","volume":"121","author":"JA Kanakry","year":"2013","unstructured":"Kanakry JA, Li H, Gellert LL, Lemas MV, Hsieh WS, Hong F, et al. Plasma Epstein\u2013Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 2013;121:3547\u201353.","journal-title":"Blood"},{"key":"1180_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jiac.2016.09.004","volume":"23","author":"BD Myriam","year":"2017","unstructured":"Myriam BD, Sonia Z, Hanene S, Teheni L, Mounir T. Prognostic significance of Epstein\u2013Barr virus (EBV) infection in Hodgkin lymphoma patients. J Infect Chemother. 2017;23:121\u201330.","journal-title":"J Infect Chemother"},{"key":"1180_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bjh.12878","volume":"166","author":"GA Follows","year":"2014","unstructured":"Follows GA, Ardeshna KM, Barrington SF, Culligan DJ, Hoskin PJ, Linch D, et al. Guidelines for the first line management of classical Hodgkin lymphoma. Br J Haematol. 2014;166:34\u201349.","journal-title":"Br J Haematol"},{"key":"1180_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V94.2.429","volume":"94","author":"G Jerusalem","year":"1999","unstructured":"Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94:429\u201333.","journal-title":"Blood"},{"key":"1180_CR19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107:52\u20139.","journal-title":"Blood"},{"key":"1180_CR20","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M, et al. Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol. 2007;25:3746\u201352.","journal-title":"J Clin Oncol"},{"key":"1180_CR21","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","volume":"30","author":"TC El-Galaly","year":"2012","unstructured":"El-Galaly TC, d\u2019Amore F, Mylam KJ, Brown PN, Bogsted M, Bukh A, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography\/computed tomography-staged treatment-na\u00efve patients with Hodgkin lymphoma. J Clin Oncol. 2012;30:4508\u201314.","journal-title":"J Clin Oncol"},{"key":"1180_CR22","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201367.","journal-title":"J Clin Oncol"},{"key":"1180_CR23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3960\/jslrt.46.5","volume":"46","author":"K Aozasa","year":"2006","unstructured":"Aozasa K. Pyothorax-associated lymphoma. J Clin Exp Hematopathol. 2006;46:5\u201310.","journal-title":"J Clin Exp Hematopathol"},{"key":"1180_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF02985123","volume":"19","author":"H Asakura","year":"2005","unstructured":"Asakura H, Togami T, Mitani M, Takashima H, Yokoe K, Yamamoto Y, et al. Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma. Ann Nucl Med. 2005;19:725\u20138.","journal-title":"Ann Nucl Med"},{"key":"1180_CR25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12149-010-0408-4","volume":"24","author":"K Ito","year":"2010","unstructured":"Ito K, Shida Y, Kubota K, Morooka M, Aruga T, Itami J, et al. The management of pyothorax-associated lymphoma using 18F-FDG PET\/CT. Ann Nucl Med. 2010;24:649\u201354.","journal-title":"Ann Nucl Med"},{"key":"1180_CR26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","volume":"122","author":"CY Ok","year":"2013","unstructured":"Ok CY, Papathomas TG, Medeiros LJ, Medeiros LJ, Young KH. EBV-positive diffuse large B-cell lymphoma of the elderly. Blood. 2013;122:328\u201340.","journal-title":"Blood"},{"key":"1180_CR27","first-page":"530","volume":"91","author":"JJ Castillo","year":"2016","unstructured":"Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016;91:530\u20137.","journal-title":"Am J Hematol"},{"key":"1180_CR28","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1158\/1078-0432.CCR-13-3157","volume":"2","author":"CY Ok","year":"2014","unstructured":"Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC, et al. Prevalence and clinical implications of Epstein\u2013Barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res. 2014;2:2338\u201349.","journal-title":"Clin Cancer Res"},{"key":"1180_CR29","doi-asserted-by":"publisher","first-page":"20160879","DOI":"10.1259\/bjr.20160879","volume":"90","author":"K Tokuyama","year":"2017","unstructured":"Tokuyama K, Okada F, Sato H, Matsumoto S, Matsumoto A, Haruno A, et al. Computed tomography findings in Epstein\u2013Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly: comparison with EBV-negative DLBCL. Br J Radiol. 2017;90:20160879. doi: 10.1259\/bjr.20160879 .","journal-title":"Br J Radiol"},{"key":"1180_CR30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PPO.0b013e31826c5e19","volume":"18","author":"M Roschewski","year":"2012","unstructured":"Roschewski M, Wilson WH. Lymphomatoid granulomatosis. Cancer J. 2012;18:469\u201374.","journal-title":"Cancer J"},{"key":"1180_CR31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3348\/kjr.2011.12.6.671","volume":"12","author":"JH Chung","year":"2011","unstructured":"Chung JH, Wu CC, Gilman MD, Palmer EL, Hasserjian RP, Shepard JA. Lymphomatoid granulomatosis: CT and FDG-PET findings. Korean J Radiol. 2011;12:671\u20138.","journal-title":"Korean J Radiol"},{"key":"1180_CR32","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bbmt.2013.07.023","volume":"19","author":"K Siegloch","year":"2013","unstructured":"Siegloch K, Schmitz N, Wu HS, Friedrichs B, van Imhoff GW, Montoto S, et al. Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report. Biol Blood Marrow Transplant. 2013;19:1522\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1180_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.seminhematol.2013.11.007","volume":"51","author":"R Suzuki","year":"2014","unstructured":"Suzuki R. Pathogenesis and treatment of extranodal natural killer\/T-cell lymphoma. Semin Hematol. 2014;51:42\u201351.","journal-title":"Semin Hematol"},{"key":"1180_CR34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00277-008-0494-8","volume":"87","author":"PL Khong","year":"2008","unstructured":"Khong PL, Pang CB, Liang R, Kwong YL, Au WY. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol. 2008;87:613\u201321.","journal-title":"Ann Hematol"},{"key":"1180_CR35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2214\/AJR.09.3665","volume":"195","author":"J Feeney","year":"2010","unstructured":"Feeney J, Horwitz S, Gonen M, Schoder H. Characterization of T-cell lymphomas by FDG-PET\/CT. Am J Roentgenol. 2010;195:333\u201340.","journal-title":"Am J Roentgenol"},{"key":"1180_CR36","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2967\/jnumed.108.053355","volume":"49","author":"C Suh","year":"2008","unstructured":"Suh C, Kang YK, Roh JL, Kim MR, Kim JS, Huh J, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer\/T-cell lymphomas of the head and neck. J Nucl Med. 2008;49:1783\u20139.","journal-title":"J Nucl Med"},{"key":"1180_CR37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","volume":"40","author":"CY Kim","year":"2013","unstructured":"Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW, et al. Prognostic value of whole-body metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma. Eur J Nucl Med Mol Imaging. 2013;40:1321\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1180_CR38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11864-011-0177-x","volume":"13","author":"D Jagadeesh","year":"2012","unstructured":"Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012;13:122\u201336.","journal-title":"Curr Treat Options Oncol"},{"key":"1180_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","volume":"13","author":"M Green","year":"2013","unstructured":"Green M, Michaels MG. Epstein\u2013Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13:41\u201354.","journal-title":"Am J Transplant"},{"key":"1180_CR40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/10428194.2013.813501","volume":"55","author":"E Panagiotidis","year":"2014","unstructured":"Panagiotidis E, Quigley AM, Pencharz D, Ardeshna K, Syed R, Sajjan R, et al. (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography in diagnosis of post-transplant lymphoproliferative disorder. Leuk Lymphoma. 2014;55:515\u20139.","journal-title":"Leuk Lymphoma"},{"key":"1180_CR41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MNM.0000000000000050","volume":"35","author":"CS Takehana","year":"2014","unstructured":"Takehana CS, Twist CJ, Mosci C, Quon A, Mittra E, Iagaru A. 18F-FDG PET\/CT in the management of patients with post-transplant lymphoproliferative disorder. Nucl Med Commun. 2014;35:276\u201381.","journal-title":"Nucl Med Commun"},{"key":"1180_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","volume":"22","author":"H Tran","year":"2008","unstructured":"Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22:261\u201381.","journal-title":"Blood Rev"},{"key":"1180_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2214\/AJR.10.6332","volume":"197","author":"JM Davison","year":"2011","unstructured":"Davison JM, Subramaniam RM, Surasi DS, Cooley T, Mercier G, Peller PJ. FDG PET\/CT in patients with HIV. Am J Roentgenol. 2011;197:284\u201394.","journal-title":"Am J Roentgenol"},{"key":"1180_CR44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","volume":"114","author":"A Johnston","year":"2005","unstructured":"Johnston A, Gudionsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol. 2005;114:154\u201363.","journal-title":"Clin Immunol"},{"key":"1180_CR45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/RLU.0b013e3182177296","volume":"36","author":"R Minamimoto","year":"2011","unstructured":"Minamimoto R, Ito K, Kubota K, Morooka M, Masuda-Miyata Y, Hirai R, et al. Clinical role of FDG PET\/CT for methotrexate-related malignant lymphoma. Clin Nucl Med. 2011;36:533\u20137.","journal-title":"Clin Nucl Med"},{"key":"1180_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12885-016-2672-8","volume":"16","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Manabe O, Hirata K, Oyama-Manabe N, Hattori N, Kikuchi Y, et al. The usefulness of 18F-FDG PET\/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC Cancer. 2016;16:635. doi: 10.1186\/s12885-016-2672-8 .","journal-title":"BMC Cancer"},{"key":"1180_CR47","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein\u2013Barr virus infection among individuals aged 6\u201319\u00a0years in the United States and factors affecting its acquisition. J Infect Dis. 2013;208:1286\u201393.","journal-title":"J Infect Dis"},{"key":"1180_CR48","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993\u20132000.","journal-title":"N Engl J Med"},{"key":"1180_CR49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0609.2008.01088.x","volume":"81","author":"MB Lustberg","year":"2008","unstructured":"Lustberg MB, Aras O, Meisenberg BR. FDG PET\/CT findings in acute adult mononucleosis mimicking malignant lymphoma. Eur J Haematol. 2008;81:154\u20136.","journal-title":"Eur J Haematol"},{"key":"1180_CR50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/RLU.0b013e3181bed135","volume":"34","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Syrbu S, Graham MM. Epstein\u2013Barr virus mimicking lymphoma on FDG-PET\/CT. Clin Nucl Med. 2009;34:891\u20133.","journal-title":"Clin Nucl Med"},{"key":"1180_CR51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1095-0397(00)00088-1","volume":"3","author":"MB Tomas","year":"2000","unstructured":"Tomas MB, Tronco GG, Karayalcin G, Palestro CJ. FDG uptake in infectious mononucleosis. Clin Positron Imaging. 2000;3:176.","journal-title":"Clin Positron Imaging"},{"key":"1180_CR52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2007.11.002","volume":"85","author":"T Liu","year":"2007","unstructured":"Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET\/CT, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol. 2007;85:327\u201335.","journal-title":"Radiother Oncol"},{"key":"1180_CR53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejrad.2012.06.031","volume":"82","author":"MC Chang","year":"2013","unstructured":"Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH. Accuracy of whole-body FDG-PET and FDG-PET\/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Eur J Radiol. 2013;82:366\u201373.","journal-title":"Eur J Radiol"},{"key":"1180_CR54","first-page":"49","volume":"4","author":"TC Lim","year":"2012","unstructured":"Lim TC, Chua ML, Chia GS, Ng DC, Ong SC, Wee JT, et al. Comparison of MRI, CT and 18F-FDG-PET\/CT for the detection of intracranial disease extension in nasopharyngeal carcinoma. Head Neck Oncol. 2012;4:49.","journal-title":"Head Neck Oncol"},{"key":"1180_CR55","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome K, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adult-onset chronic active Epstein\u2013Barr virus infection; a retrospective analysis. Int J Hematol. 2011;93:602\u20139.","journal-title":"Int J Hematol"},{"key":"1180_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bmt.2010.122","volume":"46","author":"K Kawa","year":"2011","unstructured":"Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011;46:77\u201383.","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-017-1180-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T08:51:45Z","timestamp":1602060705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-017-1180-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1007\/s12149-017-1180-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}